Navigation Links
CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
Date:2/23/2010

004, it works with over 30 academic labs worldwide to identify, patent and commercialise product opportunities. CellCentric currently has 7 novel target discovery programmes ongoing, focused on cancer, as well as multiple projects related to reprogramming and epigenetic tools. For further details on the company, see: http://www.cellcentric.com.

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website http://www.takeda.com.

SOURCE CellCentric Ltd

Back to top
'/>"/>
SOURCE CellCentric Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PSKW & Associates LLC Acquires Triax Media, Licenses Triax to Subsidiary, Centricity Group
2. TenX Biopharma Licenses Zanolimumab From Genmab
3. Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients
4. Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation
5. SCOLR Pharma, Inc. Licenses Dietary Supplements
6. StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke
7. The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
8. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
9. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
10. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
11. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Amgen (NASDAQ: AMGN ... a $0.79 per share dividend for the third quarter ... 8, 2015, to all stockholders of record as of ... About Amgen Amgen is committed to unlocking ... illnesses by discovering, developing, manufacturing and delivering innovative human ...
(Date:7/28/2015)... July 28, 2015   Heska Corporation  (NASDAQ: ... provider of  advanced veterinary diagnostic and other specialty ... the new Element i ® Immunodiagnostic Analyzer. ... for key health concerns, including thyroid disorders, Cushing,s ... a compact bench top analyzer that delivers rapid ...
(Date:7/28/2015)... LOUIS, July 28, 2015  Express Scripts Holding Company ... income attributable to Express Scripts stockholders of $600.1 million, ... share, as detailed in Table 4, were $1.44 for ... is clear many companies across healthcare are validating the ... and Chief Executive Officer. "But, what matters most is ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25
... FRANCISCO, Calif., Feb. 3 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... will delay,further partnership discussions regarding R788 until after ... are available. The company expects that,these ... the understanding of R788,s potential and may therefore,drive ...
... Feb. 2 Adolescents and young adults who ... than non-users to have disrupted brain development, according ... in areas of the brain that interconnect brain ... executive functioning skills. The findings are of particular ...
Cached Medicine Technology:Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 2Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 3Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 4Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results 5Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults 2Heavy Marijuana Use May Damage Developing Brain in Teens, Young Adults 3
(Date:7/28/2015)... ... July 28, 2015 , ... A ... outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration versus those ... to relapse to opiate use (1) and more likely to require hospitalization or ...
(Date:7/28/2015)... ... July 28, 2015 , ... Morristown Medical Center, part of Atlantic Health ... the first five hospitals in the nation, to implant the newly approved CoreValve® Evolut® ... and all are in good condition. , The CoreValve® Evolut® R System was approved ...
(Date:7/28/2015)... ... ... Healthline , a provider of intelligent health information and technology solutions, ... digital health . The survey, which was conducted among 3,679 Healthline.com ... of trust in the security of digital health tools, impact of these tools on ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Aziz Ahmad recently gave a ... place from noon to 1 p.m. Tuesday, June 23, at the Gulf Coast Regional ... Dr. Ahmad is board-certified in colorectal surgery and has more than 35 years of ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... According to ... able to stop the cycle of addiction in lab mice. The study involving isradipine ... for the new prospect of helping their clients overcome drug and alcohol addictions. The ...
Breaking Medicine News(10 mins):Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3
... Metabolic surgery, a new surgical approach to metabolic ... in some patients. This data was presented ... (AACE) 18th Annual Meeting & Clinical Congress.(Logo: ... beyond just weight-loss surgery," Chief of Gastrointestinal Metabolic ...
... issue brief highlights critical components of university,s successful program MINNEAPOLIS, ... health management program will deliver a positive return on investment ... of Louisville knows this to be true and a ... ) shows how this Louisville, Ky.-based university achieved a ROI ...
... level of overall functioning and mental health in ... recent Finnish study. , Jorvi Early psychosis Recognition ... Hospital (HUCH), Jorvi Hospital, Finland, is a project ... risk of developing first-episode psychosis. As developing psychosis ...
... secondary school is a challenge for many young people. According ... school and higher education, upper secondary school is a particularly ... school pupils are at the greatest risk: up to 20 ... phenomenon to be taken seriously, as it can lead to ...
... of certified nursing assistants (CNAs) in nursing homes reveals ... one work-related injury in the previous year. One in ... nearly half of those without medical insurance claimed they ... gathered from the first-ever National Nursing Assistant Survey (NNAS), ...
... DIEGO, May 14 Amylin Pharmaceuticals, Inc. (Nasdaq: ... response to Carl Icahn:"Icahn Associates has been criticizing our ... fair to point out, according to Icahn,s own standards, ... "Icahn,s own performance elsewhere is well documented." About Amylin ...
Cached Medicine News:Health News:Can New Surgery Revolutionize Diabetes Treatment? 2Health News:Can New Surgery Revolutionize Diabetes Treatment? 3Health News:University of Louisville Realizes Nearly 3:1 ROI with Employee Health Management 2Health News:Early and network-oriented care may help adolescents at risk of developing psychosis 2Health News:One in five girls in upper secondary school suffers from school burnout 2Health News:Nursing assistant workforce facing financial, health challenges 2Health News:Amylin Issues Statement Regarding Open Letter From Icahn 2
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
... reflection mirrors to measure the position ... tumor removal or thyroid decompression. It ... is easy to handle- with a ... plastic mounts that are placed firmly ...
Fastest, easiest and least expensive method for measuring exophthalmos. By sighting at right angles, this device eliminates parallax and allows the clinician to measure the amount of protrusion or bu...
PLX40s, 40 Watt Sealed CO2 Laser System....
Medicine Products: